Navigation Links
A Collaboration to Find New Tools to Fight Leukemia

Mayo Clinic Cancer Center, working in collaboration with Ohio State University Comprehensive Cancer Center//, presented evidence Sunday that a novel regimen of three chemotherapy drugs, pentostatin, cyclophosphamide and rituximab, resulted in significant clinical response in patients with previously untreated chronic lymphocytic leukemia (CLL). Lead researcher and Mayo Clinic hematologist Neil E. Kay, M.D., presented these findings at the 2006 American Society of Hematology Annual Meeting in Orlando.

“Chronic lymphocytic leukemia is incurable, but continues to be made more manageable with the advent of powerful new chemoimmunotherapy tools,” says Dr. Kay. “We and our collaborators at Ohio State University, in particular Dr. Michael Grever, have done previous research on pentostatin that led us to believe there would be success with this regimen, and are pleased with the results.”

Regimens using rituximab are common for CLL patients, says Dr. Kay, and his team decided to build upon that knowledge and their understanding of the highly potent chemotherapeutic antibiotic pentostatin to try to develop an even better treatment option. The investigators initiated a trial of three weeks (one cycle) of combined chemotherapy drugs pentostatin (P), cyclophosphamide (C) and rituximab (R) repeated in six cycles for 64 symptomatic but previously untreated patients. Patients in the study also received one year of prophylactic sulfamethoxazole-trimethoprim (anti-infection drug) and acyclovir (antiviral drug) along with the PCR treatment.

The researchers reviewed study participants’ prognostic status and divided the patients into risk categories at the beginning of the study, using a number of different prognostic evaluation tools to describe them, including the Rai stages (clinical levels of disease progression), CD38 and ZAP-70 (overexpressed proteins found in CLL cells), IgVH (mutational status of the immunoglobulin gene occurring in CLL patien
'"/>




Page: 1 2

Related medicine news :

1. Collaborations planned between British Organization and Indian health care industry
2. Crusade Against Cancer: Collaborations On The Anvil
3. Mayo Clinic and Indian Health Service Form Clinical Practice Collaboration
4. International Collaboration Takes Aim at Rabies
5. British Medical Association Plans Collaboration With India
6. British Medical Association Plans Collaboration With India
7. LondonMet Keen on Widening Research Collaborations With India
8. New Tools To Identify Flu Strains
9. Is There a Connection between Hearing loss and High-speed Dental Tools?
10. Software Tools & Fonts in Seven Indian Languages
11. ‘Dirty’ and Dangerous Tools Put Full Stop to Operatin
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Collaboration Find New Tools Fight Leukemia

(Date:5/29/2015)... Based in St. Louis, Missouri La La Land ... a couple of months now and are really helping spread ... “I’m not misbehaving, I have Autism, please be understanding” is ... autistic child in order to start a conversation and ultimately ... they raising awareness through the autism awareness shirts which can ...
(Date:5/29/2015)... 2015 M3 USA MDLinx.com, source of ... medical specialties, now offers The Smartest Rheumatologist . ... rheumatology disorders ranging from Fibromyalgia and Osteoporosis, to Arthritis ... of MDLinx, and Caroline Tredway, editorial head of The ... will have on the physicians who participate. Says Tredway, ...
(Date:5/29/2015)... LAKE, CO (PRWEB) May 29, 2015 ... brand new addiction, substance abuse, and co-occurring mental ... celebration and ribbon cutting for the general public ... June 2nd. , The Recovery Village at Palmer ... and intensive outpatient programming, utilizing traditional and evidence-based ...
(Date:5/29/2015)... Los Angeles, CA (PRWEB) May 29, 2015 ... Old Should You Really be When You Get Botox ... anti-aging questions according to Google. Elle partnered with Google to ... these questions. The most searched question in California, for example, ... South Carolina the most common search query is what's the ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... unit have reached a confidential Risperdal lawsuit ( ... allegedly developed gynecomastia due to his use of ... case had been selected for the third bellwether ... a mass tort litigation underway in Pennsylvania’s Philadelphia ...
Breaking Medicine News(10 mins):Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3
... understanding (MOU) with the Clinton Foundation of United States on ... as well as diagnostics for HIV/AIDS treatment and care. ... Nigerian President Olusegun Obasanjo and former U.S. president Bill Clinton ... ,According to the agreement, Nigeria is to be included ...
... the Federal Government about the impending shortage of general practitioners.// ... cent of the country’s GPs are 55 years or older, and ... next few years. ,Dr Haikerwal pointed out that the ... the work force and also to make sure that there is ...
... in collaboration with investigators at Johns Hopkins University, are ... vaccine against the West Nile virus. ,The ... its yearly appearance in Middle Tennessee. While no human ... state so far this season, mosquitoes collected from around ...
... issue 20 lakh equity shares to Ranbaxy Laboratories on a ... board of directors has approved the issue of 20 lakh ... 100 on a preferential basis to Ranbaxy, subject to shareholders' ... board also approved the allotment of shares over 1.11 crore ...
... Roche are conducting talks to make the expensive anti-cancer treatment, ... Tony Abbott discussions with manufacturer Roche has caused the delay ... , Mr Abbott said,'It is important the Government ... well as the best possible deal for patients. So we ...
... that children who use an indoor swimming pool may be ... by the Belgian researchers of the Catholic University of Louvain, ... the rates of childhood asthma and wheezing rose by around ... researchers were of the opinion that the exposure to chlorine, ...
Cached Medicine News:Health News:University Participating in West Nile Vaccine Trial 2Health News:Use Of Indoor Swimming Pools Linked To Development Of Asthma In Children 2
(Date:5/29/2015)... , May 29, 2015 Eli Lilly and ... Sachs 36th Annual Global Healthcare Conference on Tuesday, June ... and president, Elanco Animal Health, will participate in a ... A live audio webcast will be available ... website at http://investor.lilly.com/events.cfm . A replay of the ...
(Date:5/29/2015)... 29, 2015  The annual customer satisfaction survey of ... EMR as #1 across all specialties. Every year, ... conducts a poll of EHR users and publishes an ... Praxis EMR topped 348 other systems, ... based criteria used by Black Book. In addition to ...
(Date:5/29/2015)... 29, 2015 LifeNet Health plans to enlarge ... 2015 to more than 160 people. The ... LifeNet Health,s innovative bio-implants, which are being made more ... be served. It also is a reflection of the ... "The growth and success of LifeNet Health is a ...
Breaking Medicine Technology:Lilly to Participate in Goldman Sachs Global Healthcare Conference 2Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2LifeNet Health to add more than 160 jobs in 2015 2
... Switzerland, Jan. 9 ESBATech AG, a leading developer ... of the Phase I/IIa clinical development of its ... This double-blind, randomized, placebo-controlled Phase I/IIa clinical study ... efficacy on pain with ESBA105 applied locally via ...
... transplantation to be Quark,s second indication with ... Calif., Jan. 8 Quark Pharmaceuticals, Inc., ... novel RNA interference (RNAi)-based therapeutics, today announced ... its Phase I/II clinical trial evaluating its ...
Cached Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4
... GE Medical Systems Information ... see for yourself how ... Physician Office - Practice ... Manager) can simplify your ...
... The Z-1 applanation tonometer is designed ... slit lamp or most "Zeiss" style ... highly accurate intra-ocular pressure readings. The ... slit lamp and the prism is ...
... ReSeeVit 5Z slit lamp is designed ... imaging. This video-ready slit lamp offers ... It is another addition to the ... offers the best products on the ...
... is an automated, multiparametric immunoassay ... device stores the calibration in ... the cost-per-patient result. Plus, ... interface, labor cost is also ...
Medicine Products: